{
    "2021-09-26": [
        [
            {
                "time": "",
                "original_text": "医药生物行业：海外新冠治疗药物有望Q4陆续获批 重点推荐相关CDMO标的",
                "features": {
                    "keywords": [
                        "医药生物",
                        "新冠治疗药物",
                        "Q4获批",
                        "CDMO"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "长春高新：长效生长激素属于创新药",
                "features": {
                    "keywords": [
                        "长春高新",
                        "长效生长激素",
                        "创新药"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业研究周报：从医疗服务价格调整看康复行业机会(第79篇)",
                "features": {
                    "keywords": [
                        "医药生物",
                        "医疗服务",
                        "价格调整",
                        "康复行业",
                        "机会"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物",
                        "康复行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业资金流入榜：6股净流入资金超亿元",
                "features": {
                    "keywords": [
                        "医药生物",
                        "资金流入",
                        "6股",
                        "净流入",
                        "超亿元"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}